US Stock MarketDetailed Quotes

CEROW CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/29 (TO PUR COM)

Watchlist
  • 0.025
  • 0.0000.00%
Close Aug 14 09:37 ET
0Market Cap0.00P/E (TTM)

CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/29 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
113.29%5.15M
2.41M
-30.97%2.44M
3.06%11.97M
3.53M
11.62M
Selling and administrative expenses
99.39%2.43M
--1.22M
-13.30%638.35K
-14.27%2.13M
--736.28K
--2.48M
-General and administrative expense
99.39%2.43M
--1.22M
-13.30%638.35K
-14.27%2.13M
--736.28K
--2.48M
Research and development costs
127.51%2.71M
--1.19M
-35.63%1.8M
7.76%9.85M
--2.8M
--9.14M
Operating profit
-113.29%-5.15M
-2.41M
30.97%-2.44M
-3.06%-11.97M
-3.53M
-11.62M
Net non-operating interest income expense
-128.57%-16.98K
59.42K
-99.91%16
-85.60%142.12K
17.27K
986.71K
Non-operating interest income
----
--59.42K
-99.91%16
-85.60%142.12K
--17.27K
--986.71K
Non-operating interest expense
--16.98K
----
----
----
----
----
Other net income (expense)
937.56%2.72M
261.82K
Gain on sale of security
1,007.62%2.9M
--261.82K
----
----
----
----
Special income (charges)
--447.34K
--0
--0
----
----
----
-Less:Other special charges
---447.34K
----
----
----
----
----
Other non- operating income (expenses)
---630.78K
----
----
----
----
----
Income before tax
-17.02%-2.45M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Income tax
Net income
-17.02%-2.45M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Net income continuous Operations
-17.02%-2.45M
---2.09M
30.64%-2.44M
-11.28%-11.83M
---3.52M
---10.63M
Minority interest income
Net income attributable to the parent company
-17.02%-2.45M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.02%-2.45M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 113.29%5.15M2.41M-30.97%2.44M3.06%11.97M3.53M11.62M
Selling and administrative expenses 99.39%2.43M--1.22M-13.30%638.35K-14.27%2.13M--736.28K--2.48M
-General and administrative expense 99.39%2.43M--1.22M-13.30%638.35K-14.27%2.13M--736.28K--2.48M
Research and development costs 127.51%2.71M--1.19M-35.63%1.8M7.76%9.85M--2.8M--9.14M
Operating profit -113.29%-5.15M-2.41M30.97%-2.44M-3.06%-11.97M-3.53M-11.62M
Net non-operating interest income expense -128.57%-16.98K59.42K-99.91%16-85.60%142.12K17.27K986.71K
Non-operating interest income ------59.42K-99.91%16-85.60%142.12K--17.27K--986.71K
Non-operating interest expense --16.98K--------------------
Other net income (expense) 937.56%2.72M261.82K
Gain on sale of security 1,007.62%2.9M--261.82K----------------
Special income (charges) --447.34K--0--0------------
-Less:Other special charges ---447.34K--------------------
Other non- operating income (expenses) ---630.78K--------------------
Income before tax -17.02%-2.45M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Income tax
Net income -17.02%-2.45M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Net income continuous Operations -17.02%-2.45M---2.09M30.64%-2.44M-11.28%-11.83M---3.52M---10.63M
Minority interest income
Net income attributable to the parent company -17.02%-2.45M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.02%-2.45M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg